There is no reliable estimate of life expectancy for people with<unk> . The largest multi-center study of lung function in people with<unk>  across many European countries found strong evidence refuting a common assumption that it is a mild disease. This study found that lung function of people with<unk>  is comparable to those with cystic fibrosis in childhood but is better in young adulthood. Both diseases, however, are progressive and lung function declines with age relative to peer groups. Survey data indicate that respiratory symptoms increase progressively and continuously beginning in the mid-20s relative to the population norm.
Primary ciliary dyskinesia
Cystic fibrosis
Eustachian tube dysfunction
MOG antibody disease
Goldenhar syndrome
Oculopharyngeal muscular dystrophy
Adventitial cystic disease
Wolfram syndrome